Pacira BioSciences, Inc.

PCRX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G May 2, 2025
ARS Apr 29, 2025 ARS
DEFA14A Apr 29, 2025 DEFA14A
DEF 14A Apr 29, 2025 DEF 14A
SCHEDULE 13G/A Apr 28, 2025
8-K Apr 22, 2025 8-K
SCHEDULE 13G/A Apr 21, 2025
DEFA14A Apr 18, 2025 DEFA14A
DEFA14A Apr 17, 2025 DEFA14A
8-K Apr 7, 2025 8-K
8-K Mar 14, 2025 8-K
DEFA14A Mar 14, 2025 DEFA14A
DFAN14A Mar 14, 2025
144 Mar 6, 2025
S-8 Feb 27, 2025 S-8
10-K Feb 27, 2025 10-K - PCRX - 12.31.2024
8-K Feb 27, 2025 8-K
4 Feb 4, 2025 FORM 4
4 Feb 4, 2025 FORM 4
4 Feb 4, 2025 FORM 4
4 Feb 4, 2025 FORM 4
4 Feb 4, 2025 FORM 4
8-K Jan 30, 2025 8-K
3 Jan 28, 2025 FORM 3
8-K Jan 21, 2025 8-K
← Newer Page 7 of 53 · 1306 filings Older →